New appointments to AAO

Article

Dennis S.C. Lam, MD, of Hong Kong and Stefan Seregard, MD, of Sweden have been appointed to serve a one-year term on the American Academy of Ophthalmology's (AAO) Board of Trustees.

Dennis S.C. Lam, MD, of Hong Kong and Stefan Seregard, MD, of Sweden have been appointed to serve a one-year term on the American Academy of Ophthalmology's (AAO) Board of Trustees.

The International Advisor position on the AAO Board was established in 2010 to bring a global perspective to the board's decision making and policy setting. Each advisor serves a one-year term and represents one of the five major geographic world regions. In 2011, the new appointees will represent two of the remaining three regions.

“The AAO has a substantial number of international members,” said David W. Parke II, MD, executive vice president and CEO of the AAO. “At the same time, we have expanded upon and strengthened our relationships with national and supranational ophthalmic societies worldwide. We are very fortunate to add the insight of strong leaders like Dr Lam and Dr Seregard to our board of trustees and will look to them for guidance regarding our participation in the international ophthalmic community.”

Dr Lam is the chairman of the department of ophthalmology and visual sciences at the Chinese University of Hong Kong. He is the secretary-general and CEO of the Asia-Pacific Academy of Ophthalmology (APAO), and served as president and organizing committee chairman of the 2008 World Ophthalmology Congress (held in Hong Kong).

Dr Seregard is professor of ophthalmology, Karolinska Institutet, and chairman, department of vitreoretinal diseases, at St. Erik's Eye Hospital in Stockholm. He currently serves as secretary general of the European Ophthalmological Society and president of the Swedish Ophthalmological Society.

Source: American Academy of Ophthalmology

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.